tm
Seeing Is Believing
tm
Seeing Is Believing
Chinook Therapeutics's activity chart (see below) currently has 36 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 76.7% with an average time for these price targets to be met of 458.64 days.
Most recent stock forecast was given by from WEDBUSH on 08-Aug-2023. First documented stock forecast 20-Apr-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Jan-2021
$42
$1.61 (3.99%)
$36
2 years 11 months 5 days ago
(08-Aug-2023)
2/3 (66.67%)
$1.68 (4.17%)
460
Buy Since 05-Dec-2022
$30
$-10.39 (-25.72%)
$30
2 years 11 months 12 days ago
(01-Aug-2023)
1/2 (50%)
$-10.29 (-25.54%)
189
Hold Since 21-Jun-2023
$40
$-0.39 (-0.97%)
$40
3 years 22 days ago
(21-Jun-2023)
9/9 (100%)
$1.63 (4.25%)
329
Buy Since 02-Nov-2020
$40
$-0.39 (-0.97%)
$32
3 years 29 days ago
(14-Jun-2023)
2/2 (100%)
$2.37 (6.30%)
500
Buy Since 07-Oct-2020
$40
$-0.39 (-0.97%)
$44
3 years 1 months ago
(13-Jun-2023)
2/3 (66.67%)
$2.13 (5.62%)
516
What is KDNY (Chinook Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on KDNY (Chinook Therapeutics) with a proven track record?
Which analyst has the most public recommendations on KDNY (Chinook Therapeutics)?
Which analyst is the currently most bullish on KDNY (Chinook Therapeutics)?
Which analyst is the currently most reserved on KDNY (Chinook Therapeutics)?
